Ritter Pharmaceuticals starts second phase of lactose intolerance trials
Ritter Pharmaceuticals has announced the dosing of the first patient in its Phase 2b/3 clinical trial of RP-G28 for the treatment of lactose intolerance.
News, Analysis & Insights on Nutrition, Supplements, and Health
Ritter Pharmaceuticals has announced the dosing of the first patient in its Phase 2b/3 clinical trial of RP-G28 for the treatment of lactose intolerance.
The EU’s central science agency last week published draft recommendations for vitamin D intakes – 15 micrograms (µg) a day for adults – a level drawing some criticism for being too low. Others say supplement sales will rise.
Researchers at McMaster University in Canada found that, among overweight subjects, higher dietary protein intake during an energy deficit combined with intense exercise promotes greater lean mass gain and fat mass loss.
Healthcare professionals may recommend moderate dark chocolate consumption after daily chocolate eating was tied to reducing heart disease risk factors, claim the authors of a cross-sectional study.
Welsh probiotic company Cultech will use a free-trade deal to tap into the Chinese market, export ambitions that fall instep with the UK government’s plans to switch from ‘Made in China’ to ‘Made for China’.
Inaugural meeting of micronutrients and health group
A UK member of parliament (MP) will lobby for folic acid strategies including supplementation and/or fortification of flour following the inaugural meeting of a parliamentary group on micronutrients and health.